Poland· PL-100429757
Rhokiinsa
A netarsudil product containing netarsudili mesilas, registered in Poland by Santen Oy. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Netarsudil is registered in 10 of 19 countries.
Countries holding a registration under ATC S01EX05 (netarsudil), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Netarsudil · ATC S01EX05
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Netarsudili mesilas
- Manufacturer
- Santen Oy
- Country
- Poland (PL)
- ATC code
- S01EX05
- ATC class
- Netarsudil
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Netarsudil in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRhokiinsa 200 µg/mlSanten
- CzechiaRHOKIINSASanten OY, Tampere
- FinlandRhokiinsaSanten Oy
- IrelandRhokiinsa 200 micrograms/ml eye drops, solutionSanten OY
- SwedenRhokiinsa 200 mikrogram/ml Ögondroppar, lösningSanten Oy
- United StatesRhopressaAlcon Laboratories, Inc.
- IcelandRhokiinsaSanten Oy*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rhokiinsa
- Liechtenstein · Rhokiinsa
- Norway · Rhokiinsa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8a5b5402-2cfc-44f9-b998-2f0aab012925 GET /v1/drugs/8a5b5402-2cfc-44f9-b998-2f0aab012925?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "200 mcg/ml",
"packaging": "Rpz ¦ EU/1/19/1400/001 ¦ 135091\n1 butelka",
"substance": "Netarsudili mesilas 200 mcg/ml",
"common_name": "Netarsudili mesilas",
"pl_product_id": "100429757",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about netarsudil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.